Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREPARE - Intrapapillary botulinum toxin injection for prevention of post-surgical pancreatic fistula
2024-514929-33-00Phase 3Authorised
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of botulinum toxin type A in pancreatic fistula (POPF) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Clinically relevant postoperative pancreatic fistula (grade B and C). Planned start Oct 2024; status: authorised.
02
Drugs
botulinum toxin type A
03
Conditions
pancreatic fistula (POPF)
Beyond the preview
Go deeper on 2024-514929-33-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514929-33-00.